Trial · NCT07509840
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Egg retrieval in response to controlled ovarian hyperstimulation | 4 to 6 months after rituximab/placebo treatment. | Egg retrieval (yes/no) in response to controlled ovarian hyperstimulation at 4 to 6 months after rituximab treatment compared to placebo. |
| Secondary | Occurrence of spontaneous menstrual bleeding | 19-month study period from baseline to end of study. | Occurrence of spontaneous menstrual bleeding (yes/no) at any point during the 19-month study period. |
| Secondary | Proportion of participants who achieve ovulation | During 19 months from baseline to end of study. | Proportion of participants who achieve ovulation (defined as serum progesterone \>10 nmol/L) at any time during the study period. |
| Secondary | Changes in serum follicle-stimulating hormone | From baseline to the end of the study period (19 months). | Changes in serum follicle-stimulating hormone (FSH) IE/L levels from baseline to the end of the study period. |
| Secondary | Change in serum anti-Mullerian hormone | From baseline to the end of the study period (19 months). | Changes in serum anti-Mullerian hormone (AMH) microgram/L levels from baseline to the end of the study period. |
| Secondary | Changes in B-cell count | From baseline to the end of the study period (19 month). | Changes in B-cell count x109/L from baseline to end of study. |
| Secondary | Changes in autoantibody indices | From baseline to the end of the study period (19 months) | Changes in autoantibody indices from baseline to the end of the study period. |
| Secondary | Changes in immunoglobulin (IgG) levels | From baseline to the end of the study period (19 months). | Changes in immunoglobulin (IgG) g/L levels from baseline to the end of the study period. |
| Secondary | Changes in quality of life scores, as measured by the Addison's Disease Quality of Life questionnaire | From baseline to the end of the study period (19 months). | Changes in quality of life scores, as measured by the validated instrument Addison's Disease Quality of Life (AddiQol) from baseline to the end of the study period. |
| Secondary | Changes in quality life scores, as measured by the Psychological General Well-being questionnaire | From baseline to the end of the study period (19 months). | Changes in quality life scores, as measured by the validated Psychological General Well-being (PGWB) from baseline to the end of the study period. |
| Secondary | Changes in quality of life scores, as measured by the Short Form Health Survey | From baseline to the end of the study period (19 months). | Changes in quality of life scores as measured by the validated instrument Short Form Health Survey (SF-36) from baseline to the end of the study period. |
| Secondary | Changes in quality of life scores as measured by the Menopause Rating Scale | From baseline to the end of the study period (19 months). | Changes in qualit of life scores, as measured by the validated Menopause Rating Scale (MRS) from baseline to the end of the study period. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07509840/registered